Lipoma of the heart: a case report.
Nicola Maurea(Cancer Institute (WIA)), R Bellitti, Antonio Mollo(Northwestern University), M Boccalatte, Salvatore Esposito, Lucio Agozzino
PubMed
August 1, 2001
Cited by 9
Related Papers
The SGLT-2 inhibitor empagliflozin improves myocardial strain, reduces cardiac fibrosis and pro-inflammatory cytokines in non-diabetic mice treated with doxorubicin
|Cardiovascular Diabetology|2021|368
The management of Asherman syndrome: a review of literature
|Reproductive Biology and Endocrinology|2013|263